
Scholar Rock Announce New 36-Month Apitegromab Extension Data
Scholar Rock have announced new 36-Month Apitegromab Extension Data which reinforces long-term substantial and sustained improvement of motor function in phase 2 Topaz trial patients…
UK campaign for access to treatments and support for those with spinal muscular atrophy
A comprehensive guide to what SMA is
and what to be aware of.
Everything you need to know about treatments available now and future.
SMA experts have developed and published consensus guidelines on SMA care.
Scholar Rock have announced new 36-Month Apitegromab Extension Data which reinforces long-term substantial and sustained improvement of motor function in phase 2 Topaz trial patients…
Scholar Rock have announced new 36-Month Apitegromab Extension Data which reinforces long-term substantial and sustained improvement of motor function in phase 2 Topaz trial patients…
On Wednesday 12th July 2023, 7pm to 8pm the National Institute for Health and Care Research, which supports delivery of research in the NHS, public health…
On Wednesday 12th July 2023, 7pm to 8pm the National Institute for Health and Care Research, which supports delivery of research in the NHS, public health…
Are you interested in participating in two telephone/video interviews to discuss your experience of Spinal Muscular Atrophy (SMA) and to help us understand what an…
Are you interested in participating in two telephone/video interviews to discuss your experience of Spinal Muscular Atrophy (SMA) and to help us understand what an…
Despite their already reading treatments available the world of science never stops. They continues to be active trials and development on a number of new treatments. Below is the current position to the best of our knowledge of each, and this will be updated as we receive further updates